CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE

USPTO Patent Application US 2017/0189351 A1
Application Date: Jul. 6th, 2017

ABSTRACT

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL® tablet....
Application Number:
15/465,926
International Classification:
A61K 31/135 (20060101)
No Pictures Available

CLAIMS

We claim:

1. An extended-release capsule dosage form of metoprolol succinate wherein the dosage form is administered without regard to the meals.

DESCRIPTION

FIELD OF THE INVENTION

The present invention provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units and processes for their preparation.
Back to Top